Inventor

Richard J. Wurtman

Inventor

Boston, MA, US

Overview

69→

Patents

1980–2020

Patent span

Human necessities

Primary field (CPC A)

Patents· 69 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes51%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%

A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for10%

A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or propionic acid bacteria used in foodstuffs or food preparation7%

G01NInvestigating or analysing materials by determining their chemical or physical properties4%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3%

G06FElectric digital data processing2%

Y02ATechnologies for adaptation to climate change2%

C07HSugars1%

G01RMeasuring electric variables1%

PatentTitleYear

10,736,912Compositions containing PUFA and/or uridine and methods of use thereof2020 10,525,071Compositions containing PUFA and methods of use thereof2020 10,086,009Compositions containing pufa and/or uridine and methods of use thereof2018 9,572,830'Uridine effects on dopamine release'2017 8,691,775'Use of drugs that activate P2Y receptors to enhance synaptogenesis'2014 8,551,452'Uridine dietary supplementation compliance methods and use thereof'2013 8,518,882'Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same'2013 8,314,064'Uridine administration stimulates membrane production'2012 8,143,234'Uridine administration improves phosphatide synthesis, synaptic transmission and cognitive function'2012 7,011,857'Weight loss compositions and methods for individuals who may have gastric hyperacidity'2006 6,989,376'Methods for increasing blood cytidine and/or uridine levels and treating cytidine-dependent human diseases'2006 6,579,899'Composition for treatment of stress'2003 6,469,055'Compositions and methods for treatment of neurological disorders and neurodegenerative diseases'2002 6,333,317'Regulation of amyloid precursor protein (APP) expression by administration of an estrogenic compound'2001 6,329,155'Methods of identifying agents which regulate release of amyloid precursor protein'2001 6,187,756'Composition and methods for treatment of neurological disorders and neurodegenerative diseases'2001 6,184,248'Compositions and methods for treatment of neurological disorders and neurodegenerative diseases'2001 6,043,224'Compositions and methods for treatment of neurological disorders and neurodegenerative diseases'2000 5,962,463'Methods of stimulating non-amyloidogenic processing of the amyloid precursor protein'1999 5,698,525'Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (LNAA)'1997 5,641,801'Method of reducing the period before the onset of sleep'1997 5,631,168'Antemortem diagnostic test for Alzheimer\'s disease'1997 5,595,772'Composition and methods for losing weight'1997 5,545,566'Antemortem diagnostic test for alzheimer\'s disease'1996 5,449,683'Methods of inducing sleep using melatonin'1995 5,432,162'Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (LNAA)'1995 5,223,540'Method for treating the premenstrual or late luteal phase syndrome'1993 5,206,218'Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (LNAA)'1993 5,179,126'Compositions for treating tobacco withdrawl symtoms and methods for their use'1993 5,118,670'Process and composition for increasing brain dopamine release'1992 5,096,712'Method for enhancing performance so as to improve vigor and decrease fatigue, confusion, tension, and anxiety'1992 5,051,410'Method and composition for enhancing the release of neurotransmitters'1991 5,019,594'Method for decreasing appetite'1991 4,999,382'Compositions for treating tobacco withdrawal symptoms and methods for their use'1991 4,971,998'Methods for treating the premenstrual or late luteal phase syndrome'1990 4,927,853'Composition for increasing blood pressure'1990 4,885,312'Method for enhancing the effect of indirect-acting sympathomimetic amines'1989 4,775,665'Method and composition for treating neurological disorders and aging'1988 4,745,130'Composition for increasing blood pressure'1988 4,737,489'Method and composition for treating neurological disorders and aging'1988 4,687,763'Composition and method for increasing levels or release of brain serotonin'1987 4,673,689'Method and composition for enhancing the effect of indirect-acting sympathomimetic amines'1987 4,649,161'Method for treating depression with d-fenfluramine'1987 4,636,494'Process and composition for treating disorders by administering amphetamine and choline'1987 4,626,527'Process for utilizing choline to sustain muscular performance'1986 4,624,852'Process and composition for treating neurological disorders and aging'1986 4,609,647'Cytidyl diphosphocholine-drug composition and process'1986 4,598,094'Method and composition for enhancing the effect of indirect-acting sympathomimetic amines'1986 4,569,929'Cytidyl diphosphocholine-drug composition'1986 4,542,123'Composition and method for increasing brain tyrosine levels'1985 4,470,987'Process for treatment and prevention of ventricular fibrillation'1984 4,456,598'Process and composition for treating disorders by administering a butyrophenone and a choline'1984 4,452,815'Method of utilizing d,l-fenfluramine for modifying feeding behavior'1984 4,435,424'Process for improving vigor and mood in normal human patients'1984 4,430,330'Process and composition for treating disorders by administering a phenothiazine and choline'1984 4,405,629'Process for increasing glycine levels in the brain and spinal cord'1983 4,397,866'Process for increasing glycine levels in the brain and spinal cord'1983 4,377,595'Process for reducing depression'1983 4,355,027'Process and composition for treating disorders by administering piracetam and choline'1982 4,351,831'Process and composition for treating disorders by administering isoxsurpine and choline'1982 4,346,084'Process and composition for treating disorders by administering lithium and choline'1982 4,346,085'Process and composition for treating disorders by administering amphetamine and choline'1982 4,327,112'Process for increasing blood pressure'1982 4,309,445'd-Fenfluramine for modifying feeding behavior'1982 4,296,119'Process and composition for reducing blood pressure in animals'1981 4,271,192'Process for treatment and prevention of ventricular fibrillation'1981 4,224,343'Process and composition for decreasing blood serum prolactin levels'1980 4,221,784'Process and composition for treating disorders by administering lecithin'1980 4,210,637'Composition and method for suppressing appetite for calories as carbohydrates'1980

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1980–2020Patents assigned to MASSACHUSETTS INST TECHNOLOGY (61)· patent assignee history

1980–1983Based in Waban, MA, US· patent location history

1981–2020Based in Boston, MA, US· patent location history

1991–1997Patents assigned to INTERNEURON PHARMA (5)· patent assignee history

2012–2020Patents assigned to WURTMAN RICHARD J (5)· patent assignee history

2013–2014Patents assigned to WURTMAN RICHARD (3)· patent assignee history

2018–2020Patents assigned to RICHARDSON INGRID (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
MASSACHUSETTS INST TECHNOLOGY	61	1980–2020
INTERNEURON PHARMA	5	1991–1997
WURTMAN RICHARD Jself	5	2012–2020
WURTMAN RICHARDself	3	2013–2014
RICHARDSON INGRID	2	2018–2020

Locations

Location	Patents	Span
Boston, Massachusetts, US	62	1981–2020
Waban, Massachusetts, US	7	1980–1983